S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Biden's pick to lead FAA withdraws amid shaky Senate support
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Adele extends Las Vegas residency, plans concert film
NYSE:NVST

Envista - NVST Stock Forecast, Price & News

$38.24
+0.47 (+1.24%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$37.51
$38.39
50-Day Range
$35.41
$42.50
52-Week Range
$31.67
$52.03
Volume
1.04 million shs
Average Volume
1.91 million shs
Market Capitalization
$6.24 billion
P/E Ratio
27.91
Dividend Yield
N/A
Price Target
$46.00

Envista MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
20.3% Upside
$46.00 Price Target
Short Interest
Bearish
7.71% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.71
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$379,606 Sold Last Quarter
Proj. Earnings Growth
13.68%
From $1.90 to $2.16 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

562nd out of 1,005 stocks

Dental Equipment & Supplies Industry

4th out of 5 stocks


NVST stock logo

About Envista (NYSE:NVST) Stock

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

NVST Stock News Headlines

Envista (NYSE:NVST) Sees Large Volume Increase
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Envista Reports Fourth Quarter 2022 Earnings
Envista Schedules Fourth Quarter 2022 Earnings Call
Envista Reports Third Quarter 2022 Earnings
Envista (NVST) Q3 Earnings Match Estimates
Envista Announces Release of 2021 Sustainability Report
See More Headlines
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

NVST Company Calendar

Last Earnings
2/08/2023
Today
3/26/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Employees
12,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$46.00
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+20.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$243.10 million
Pretax Margin
11.05%

Debt

Sales & Book Value

Annual Sales
$2.57 billion
Cash Flow
$3.18 per share
Book Value
$25.80 per share

Miscellaneous

Free Float
161,991,000
Market Cap
$6.24 billion
Optionable
Optionable
Beta
1.42

Key Executives

  • Mr. Amir AghdaeiMr. Amir Aghdaei (Age 64)
    Pres, CEO & Director
    Comp: $4.5M
  • Mr. Howard H. YuMr. Howard H. Yu (Age 50)
    Sr. VP & CFO
    Comp: $1.23M
  • Mr. Mark E. NanceMr. Mark E. Nance (Age 54)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $1.1M
  • Mr. Patrik Eriksson (Age 55)
    Sr. VP & Pres of Nobel Biocare
    Comp: $1.17M
  • Mr. Jean-Claude E. Kyrillos (Age 59)
    Sr. VP and Pres of Diagnostics & Digital Solutions
    Comp: $1.01M
  • Juan Arbona
    Chief Compliance Officer
  • Mr. Mischa M. ReisMr. Mischa M. Reis (Age 50)
    Sr. VP of Strategy & Corp. Devel.
  • Mr. Filippo Impieri
    Sr. VP of Emerging Markets
  • Ms. Claudia Ortiz
    Sr. VP of Regulatory Affairs & Quality Assurance
  • Mr. Eric Conley
    Sr. VP of Orthodontics













NVST Stock - Frequently Asked Questions

Should I buy or sell Envista stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Envista in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NVST shares.
View NVST analyst ratings
or view top-rated stocks.

What is Envista's stock price forecast for 2023?

5 Wall Street analysts have issued 1-year target prices for Envista's stock. Their NVST share price forecasts range from $43.00 to $50.00. On average, they expect the company's share price to reach $46.00 in the next year. This suggests a possible upside of 20.3% from the stock's current price.
View analysts price targets for NVST
or view top-rated stocks among Wall Street analysts.

How have NVST shares performed in 2023?

Envista's stock was trading at $33.67 at the beginning of 2023. Since then, NVST stock has increased by 13.6% and is now trading at $38.24.
View the best growth stocks for 2023 here
.

When is Envista's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our NVST earnings forecast
.

How were Envista's earnings last quarter?

Envista Holdings Co. (NYSE:NVST) released its quarterly earnings results on Wednesday, February, 8th. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.03. The business earned $660.80 million during the quarter, compared to the consensus estimate of $658.40 million. Envista had a net margin of 9.46% and a trailing twelve-month return on equity of 8.52%. The business's revenue for the quarter was up 1.4% on a year-over-year basis. During the same period last year, the company earned $0.46 earnings per share.

What is Amir Aghdaei's approval rating as Envista's CEO?

9 employees have rated Envista Chief Executive Officer Amir Aghdaei on Glassdoor.com. Amir Aghdaei has an approval rating of 21% among the company's employees. This puts Amir Aghdaei in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Envista IPO?

(NVST) raised $603 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

What is Envista's stock symbol?

Envista trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVST."

Who are Envista's major shareholders?

Envista's stock is owned by a variety of retail and institutional investors. Top institutional investors include Boston Partners (4.30%), Artisan Partners Limited Partnership (3.72%), Dimensional Fund Advisors LP (3.42%), Ariel Investments LLC (3.09%), Alliancebernstein L.P. (2.58%) and Montrusco Bolton Investments Inc. (2.57%). Insiders that own company stock include Amir Aghdaei, Curt W Bludworth, Curt W Bludworth, Howard H Yu, Jeffrey Kappler, Mark E Nance, Mark E Nance and Mischa Reis.
View institutional ownership trends
.

How do I buy shares of Envista?

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Envista's stock price today?

One share of NVST stock can currently be purchased for approximately $38.24.

How much money does Envista make?

Envista (NYSE:NVST) has a market capitalization of $6.24 billion and generates $2.57 billion in revenue each year. The company earns $243.10 million in net income (profit) each year or $1.37 on an earnings per share basis.

How many employees does Envista have?

The company employs 12,700 workers across the globe.

How can I contact Envista?

Envista's mailing address is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. The official website for the company is www.envistaco.com. The company can be reached via phone at 714-817-7000, via email at ir@envistaco.com, or via fax at 714-817-5450.

This page (NYSE:NVST) was last updated on 3/26/2023 by MarketBeat.com Staff